{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:40:41Z","timestamp":1791294041005,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s10787-024-01623-8","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T01:58:50Z","timestamp":1734919130000},"page":"121-133","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Mechanisms and clinical applications of palmitoylethanolamide (PEA) in the treatment of neuropathic pain"],"prefix":"10.1007","volume":"33","author":[{"given":"Ardra","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8268-0828","authenticated-orcid":false,"given":"Preetha","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"issue":"4","key":"1623_CR2","first-page":"353","volume":"20","author":"BB Artukoglu","year":"2017","unstructured":"Artukoglu BB, Beyer C, Zuloff-Shani A, Brener E, Bloch MH (2017) Efficacy of palmitoylethanolamide for pain: A meta-analysis. Pain Phys 20(4):353\u2013362.","journal-title":"Pain Phys"},{"key":"1623_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5402\/2011\/917350","volume":"2011","author":"C Bacci","year":"2011","unstructured":"Bacci C, Cassetta G, Emanuele B, Berengo M (2011) Randomized split-mouth study on postoperative effects of palmitoylethanolamide for impacted lower third molar surgery. ISRN Surg 2011:1\u20136. https:\/\/doi.org\/10.5402\/2011\/917350","journal-title":"ISRN Surg"},{"key":"1623_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/cns.12648","volume":"23","author":"B Bertolino","year":"2017","unstructured":"Bertolino B, Crupi R, Impellizzeri D et al (2017) Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide\/Luteolin in a Mouse Model of Autism and in a Case Report of Autism. CNS Neurosci Ther 23:87\u201398. https:\/\/doi.org\/10.1111\/cns.12648","journal-title":"CNS Neurosci Ther"},{"key":"1623_CR4","doi-asserted-by":"publisher","first-page":"690","DOI":"10.4236\/fns.2022.137050","volume":"13","author":"D Briskey","year":"2022","unstructured":"Briskey D, Ebelt P, Steels E et al (2022) Efficacy of Palmitoylethanolamide (Levagen+<sup>TM<\/sup>) compared to ibuprofen for reducing headache pain severity and duration in healthy adults: a double-blind, parallel, randomized clinical trial. Food Nutr Sci 13:690\u2013701. https:\/\/doi.org\/10.4236\/fns.2022.137050","journal-title":"Food Nutr Sci"},{"key":"1623_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4720532","author":"MR Bronzuoli","year":"2018","unstructured":"Bronzuoli MR, Facchinetti R, Steardo L et al (2018) Palmitoylethanolamide dampens reactive astrogliosis and improves neuronal trophic support in a triple transgenic model of Alzheimer\u2019s disease: in vitro and in vivo evidence. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2018\/4720532","journal-title":"Oxid Med Cell Longev"},{"key":"1623_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s12975-015-0440-8","volume":"7","author":"C Caltagirone","year":"2016","unstructured":"Caltagirone C, Cisari C, Schievano C et al (2016) Co-ultramicronized Palmitoylethanolamide\/Luteolin in the treatment of cerebral ischemia: from rodent to man. Transl Stroke Res 7:54\u201369. https:\/\/doi.org\/10.1007\/s12975-015-0440-8","journal-title":"Transl Stroke Res"},{"key":"1623_CR7","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.bbrc.2005.03.095","volume":"330","author":"J Chen","year":"2005","unstructured":"Chen J, Matias I, Dinh T, Lu T, Venezia S, Nieves A, Woodward DF, Di Marzo V (2005) Finding of endocannabinoids in human eye tissues: Implications for glaucoma. Finding End Biochem Biophysical Research Communications 330:1062\u20131067","journal-title":"Finding End Biochem Biophysical Research Communications"},{"issue":"10","key":"1623_CR8","doi-asserted-by":"publisher","first-page":"5305","DOI":"10.3390\/ijms22105305","volume":"22","author":"P Clayton","year":"2021","unstructured":"Clayton P, Hill M, Bogoda N et al (2021) Palmitoylethanolamide: a natural compound for health management. Int J Mol Sci 22(10):5305","journal-title":"Int J Mol Sci"},{"key":"1623_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejogrb.2011.04.011","volume":"158","author":"L Cobellis","year":"2011","unstructured":"Cobellis L, Castaldi MA, Giordano V et al (2011) Effectiveness of the association micronized N-Palmitoylethanolamine (PEA)-transpolydatin in the treatment of chronic pelvic pain related to endometriosis after laparoscopic assessment: a pilot study. Eur J Obstetrics Gynecol Reproductive Biol 158:82\u201386. https:\/\/doi.org\/10.1016\/j.ejogrb.2011.04.011","journal-title":"Eur J Obstetrics Gynecol Reproductive Biol"},{"key":"1623_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-019-1514-4","volume":"16","author":"G Contarini","year":"2019","unstructured":"Contarini G, Franceschini D, Facci L et al (2019) A co-ultramicronized palmitoylethanolamide\/luteolin composite mitigates clinical score and disease-relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitis. J Neuroinflammation 16:1\u201313","journal-title":"J Neuroinflammation"},{"key":"1623_CR11","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1089\/neu.2014.3460","volume":"33","author":"M Cordaro","year":"2016","unstructured":"Cordaro M, Impellizzeri D, Paterniti I et al (2016) Neuroprotective effects of Co-UltraPEALut on secondary inflammatory process and autophagy involved in traumatic brain injury. J Neurotrauma 33:132\u2013146. https:\/\/doi.org\/10.1089\/neu.2014.3460","journal-title":"J Neurotrauma"},{"key":"1623_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.taap.2017.06.005","volume":"329","author":"M Cordaro","year":"2017","unstructured":"Cordaro M, Impellizzeri D, Siracusa R et al (2017) Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia. Toxicol Appl Pharmacol 329:231\u2013240. https:\/\/doi.org\/10.1016\/j.taap.2017.06.005","journal-title":"Toxicol Appl Pharmacol"},{"key":"1623_CR13","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2174\/18715273113129990084","volume":"12","author":"RPIAACMEECS Crupi","year":"2013","unstructured":"Crupi RPIAACMEECS (2013) Effects of Palmitoylethanolamide and Luteolin in an Animal Model of Anxiety\/Depression. CNS Neurol Disord Drug Targets 12:989\u20131001","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"1623_CR14","doi-asserted-by":"publisher","first-page":"8455","DOI":"10.1007\/s12035-018-0959-2","volume":"55","author":"R Crupi","year":"2018","unstructured":"Crupi R, Impellizzeri D, Cordaro M et al (2018) N-palmitoylethanolamide Prevents Parkinsonian Phenotypes in Aged Mice. Mol Neurobiol 55:8455\u20138472. https:\/\/doi.org\/10.1007\/s12035-018-0959-2","journal-title":"Mol Neurobiol"},{"key":"1623_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s40122-015-0038-6","volume":"4","author":"R Del Giorno","year":"2015","unstructured":"Del Giorno R, Skaper S, Paladini A et al (2015) Palmitoylethanolamide in fibromyalgia: results from prospective and retrospective observational studies. Pain Ther 4:169\u2013178. https:\/\/doi.org\/10.1007\/s40122-015-0038-6","journal-title":"Pain Ther"},{"key":"1623_CR16","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fphar.2016.00382","volume":"7","author":"R Di Paola","year":"2016","unstructured":"Di Paola R, Fusco R, Gugliandolo E et al (2016) Co-micronized palmitoylethanolamide\/polydatin treatment causes endometriotic lesion regression in a rodent model of surgically induced endometriosis. Front Pharmacol 7:382","journal-title":"Front Pharmacol"},{"key":"1623_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejphar.2016.03.033","volume":"782","author":"E Esposito","year":"2016","unstructured":"Esposito E, Impellizzeri D, Bruschetta G et al (2016) A new co-micronized composite containing palmitoylethanolamide and polydatin shows superior oral efficacy compared to their association in a rat paw model of carrageenan-induced inflammation. Eur J Pharmacol 782:107\u2013118. https:\/\/doi.org\/10.1016\/j.ejphar.2016.03.033","journal-title":"Eur J Pharmacol"},{"key":"1623_CR18","unstructured":"Esposito E, Cuzzocrea S (2013a) Send Orders of Reprints at bspsaif@emirates.net.ae Mini-Reviews in Medicinal Chemistry"},{"key":"1623_CR19","unstructured":"Esposito E, Cuzzocrea S (2013b) Send Orders of Reprints at bspsaif@emirates.net.ae Mini-Reviews in Medicinal Chemistry"},{"key":"1623_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10195-017-0453-z","volume":"18","author":"J Faig-Mart\u00ed","year":"2017","unstructured":"Faig-Mart\u00ed J, Mart\u00ednez-Catass\u00fas A (2017) Use of palmitoylethanolamide in carpal tunnel syndrome: a prospective randomized study. J Orthop Traumatol 18:451\u2013455. https:\/\/doi.org\/10.1007\/s10195-017-0453-z","journal-title":"J Orthop Traumatol"},{"key":"1623_CR21","first-page":"1252","volume":"98","author":"C Fetzer","year":"2017","unstructured":"Fetzer C (2017) Im Test: Neue analgetische und antiphlogistische Wirkstoffzubereitung. Praktische Tierarzt 98:1252","journal-title":"Praktische Tierarzt"},{"key":"1623_CR22","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1460-9568.2008.06377.x","volume":"28","author":"Frida Lor\u0131\u00b4a SPLMASFCMHCGVDMFD,","year":"2008","unstructured":"Frida Lor\u0131\u00b4a SPLMASFCMHCGVDMFD, (2008) Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide. Eur J Neurosci 28:633\u2013641","journal-title":"Eur J Neurosci"},{"key":"1623_CR23","doi-asserted-by":"publisher","unstructured":"G\u00e1lvez Mateos R, Aguilar Ros A (2023) Actualizaci\u00f3n pr\u00e1ctica sobre la palmitoiletanolamida (PEAum) oral en el manejo del dolor cr\u00f3nico. Revisi\u00f3n narrativa. Multidisciplinary Pain Journal. https:\/\/doi.org\/10.20986\/mpj.2023.1044\/2023","DOI":"10.20986\/mpj.2023.1044\/2023"},{"key":"1623_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.phrs.2017.06.014","volume":"123","author":"E Gugliandolo","year":"2017","unstructured":"Gugliandolo E, Fusco R, Biundo F et al (2017) Palmitoylethanolamide and Polydatin combination reduces inflammation and oxidative stress in vascular injury. Pharmacol Res 123:83\u201392. https:\/\/doi.org\/10.1016\/j.phrs.2017.06.014","journal-title":"Pharmacol Res"},{"key":"1623_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar4382","volume":"15","author":"D Impellizzeri","year":"2013","unstructured":"Impellizzeri D, Esposito E, Di Paola R et al (2013) Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice. Arthritis Res Therapy 15:1\u201314","journal-title":"Arthritis Res Therapy"},{"key":"1623_CR26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ejphar.2015.05.010","volume":"762","author":"D Impellizzeri","year":"2015","unstructured":"Impellizzeri D, Bruschetta G, Ahmad A et al (2015) Effects of palmitoylethanolamide and silymarin combination treatment in an animal model of kidney ischemia and reperfusion. Eur J Pharmacol 762:136\u2013149. https:\/\/doi.org\/10.1016\/j.ejphar.2015.05.010","journal-title":"Eur J Pharmacol"},{"key":"1623_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.nbd.2019.01.007","volume":"125","author":"D Impellizzeri","year":"2019","unstructured":"Impellizzeri D, Siracusa R, Cordaro M et al (2019) N-Palmitoylethanolamine-oxazoline (PEA-OXA): a new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an experimental model of repeated bilateral common carotid arteries occlusion. Neurobiol Dis 125:77\u201391. https:\/\/doi.org\/10.1016\/j.nbd.2019.01.007","journal-title":"Neurobiol Dis"},{"key":"1623_CR28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/02601060211019669","volume":"28","author":"D Kamper","year":"2022","unstructured":"Kamper D (2022) Palmitoylethanolamide (PEA) in the treatment of neuropathic pain: a case study. Nutr Health 28:265\u2013269. https:\/\/doi.org\/10.1177\/02601060211019669","journal-title":"Nutr Health"},{"key":"1623_CR29","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2147\/JPR.S48653","volume":"6","author":"JM Keppel Hesselink","year":"2013","unstructured":"Keppel Hesselink JM (2013) Evolution in pharmacologic thinking around the natural analgesic palmitoylethanolamide: From nonspecific resistance to PPAR-\u03b1 agonist and effective nutraceutical. J Pain Res 6:625\u2013634","journal-title":"J Pain Res"},{"issue":"20","key":"1623_CR30","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.1021\/ja01577a066","volume":"79","author":"FA Kuehl Jr","year":"1957","unstructured":"Kuehl FA Jr., Jacob TA, Ganley OH, Ormond RE, Meisinger MAP (1957) The identification of N-(2-hydroxyethyl)-palmitamide as a naturally occurring anti-inflammatory agent. J Am Chem Soc 79(20):5577\u20135578. https:\/\/doi.org\/10.1021\/ja01577a066","journal-title":"J Am Chem Soc"},{"issue":"6","key":"1623_CR31","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2174\/0929867023370707","volume":"9","author":"DM Lambert","year":"2002","unstructured":"Lambert DM, Vandevoorde S, Jonsson K-O, Fowler CJ (2002) The Palmitoylethanolamide family: a new class of anti-inflammatory agents? Current Medicinal Chem 9(6):663\u2013674","journal-title":"Current Medicinal Chem"},{"key":"1623_CR32","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3390\/biom12050667","volume":"12","author":"E Landolfo","year":"2022","unstructured":"Landolfo E, Cutuli D, Petrosini L, Caltagirone C (2022) Effects of palmitoylethanolamide on neurodegenerative diseases: a review from rodents to humans. Biomolecules 12:667","journal-title":"Biomolecules"},{"issue":"664","key":"1623_CR33","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(51)92609-8","volume":"257","author":"DA Long","year":"1951","unstructured":"Long DA, Miles AA, Perry WL (1951) Action of ascorbic acid on tuberculin-sensitivity in guineapigs and its modification by dietary and hormonal factors. The Lancet 257(664):1085\u20131088","journal-title":"The Lancet"},{"key":"1623_CR34","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/j.lfs.2005.05.012","volume":"77","author":"J LoVerme","year":"2005","unstructured":"LoVerme J, La Rana G, Russo R et al (2005) The search for the palmitoylethanolamide receptor. Life Sci 77:1685\u20131698","journal-title":"Life Sci"},{"key":"1623_CR35","first-page":"99","volume":"26","author":"I Marini","year":"2012","unstructured":"Marini I, Professor D, Lavinia Bartolucci M et al (2012) Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory. Pain 26:99","journal-title":"Pain"},{"key":"1623_CR36","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/BF00560353","volume":"7","author":"K Ma\u0161ek","year":"1974","unstructured":"Ma\u0161ek K, Perl\u00edk F, Kl\u00edma J, Kahlich R (1974) Prophylactic Efficacy of N-2-Hydroxyethyl palmitamide (Impulsin\u00ae)* in Acute Respiratory Tract Infections. Eur J Clin Pharmacol 7:415\u2013419","journal-title":"Eur J Clin Pharmacol"},{"key":"1623_CR37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.phrs.2014.05.006","volume":"86","author":"G Mattace Raso","year":"2014","unstructured":"Mattace Raso G, Russo R, Calignano A, Meli R (2014) Palmitoylethanolamide in CNS health and disease. Pharmacol Res 86:32\u201341","journal-title":"Pharmacol Res"},{"issue":"2","key":"1623_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/LGT.0b013e3182652316","volume":"17","author":"F Murina","year":"2013","unstructured":"Murina F, Graziottin A, Felice R et al (2013) Vestibulodynia: Synergy Between Palmitoylethanolamide + Transpolydatin and Transcutaneous Electrical Nerve Stimulation. J Lower Genital Tract Disease 17(2):111\u2013116","journal-title":"J Lower Genital Tract Disease"},{"key":"1623_CR39","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0021-9258(18)97531-9","volume":"240","author":"N. R. Bachur KMKLMSU","year":"1965","unstructured":"N. R. Bachur KMKLMSU (1965) Fatty acid amides of ethanol-amine in mammalian tissues. J Biol Chem 240:1019\u20131024","journal-title":"J Biol Chem"},{"key":"1623_CR40","doi-asserted-by":"publisher","DOI":"10.4172\/neuropsychiatry.1000549","author":"E Palazzo","year":"2019","unstructured":"Palazzo E, Luongo L, Guida F et al (2019) Role of N-Acylethanolamines in the Neuroinflammation: Ultramicronized Palmitoylethanolamide in the Relief of Chronic Pain and Neurodegenerative DiseasesRole of N-Acylethanolamines in the Neuroinflammation: Ultramicronized Palmitoylethanolamide in the Relief of Chronic Pain and Neurodegenerative Diseases. Neuropsychiatry. https:\/\/doi.org\/10.4172\/neuropsychiatry.1000549","journal-title":"Neuropsychiatry"},{"key":"1623_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-10-91","volume":"10","author":"I Paterniti","year":"2013","unstructured":"Paterniti I, Impellizzeri D, Di PR et al (2013) A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury. J Neuroinflammation 10:1\u201311","journal-title":"J Neuroinflammation"},{"key":"1623_CR42","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.3390\/nu11092175","volume":"11","author":"AF Peritore","year":"2019","unstructured":"Peritore AF, Siracusa R, Crupi R, Cuzzocrea S (2019) Therapeutic efficacy of palmitoylethanolamide and its new formulations in synergy with different antioxidant molecules present in diets. Nutrients 11:2175","journal-title":"Nutrients"},{"key":"1623_CR43","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1002\/ptr.6978","volume":"35","author":"M Pesce","year":"2021","unstructured":"Pesce M, Seguella L, Cassarano S et al (2021) Phytotherapics in COVID19: Why palmitoylethanolamide? Phytother Res 35:2514\u20132522","journal-title":"Phytother Res"},{"key":"1623_CR44","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s10787-022-01033-8","volume":"30","author":"E Pickering","year":"2022","unstructured":"Pickering E, Steels EL, Steadman KJ et al (2022) A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating diabetic-related peripheral neuropathic pain. Inflammopharmacology 30:2063\u20132077. https:\/\/doi.org\/10.1007\/s10787-022-01033-8","journal-title":"Inflammopharmacology"},{"key":"1623_CR45","doi-asserted-by":"publisher","first-page":"10468","DOI":"10.1038\/s41598-020-67527-z","volume":"10","author":"GCM Rossi","year":"2020","unstructured":"Rossi GCM, Scudeller L, Lumini C et al (2020) Effect of palmitoylethanolamide on inner retinal function in glaucoma: a randomized, single blind, crossover, clinical trial by pattern-electroretinogram. Sci Rep 10:10468","journal-title":"Sci Rep"},{"issue":"1","key":"1623_CR46","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2174\/1871527311312010011","volume":"12","author":"C Scuderi","year":"2013","unstructured":"Scuderi C, Steardo L (2013) Send orders of reprints at reprints@benthamscience.net neuroglial roots of neurodegenerative diseases: therapeutic potential of palmitoylethanolamide in models of Alzheimer\u2019s disease. CNS Neurological Disorders Drug Targets 12(1):62\u201369","journal-title":"CNS Neurological Disorders Drug Targets"},{"key":"1623_CR47","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s10787-019-00582-9","volume":"27","author":"E Steels","year":"2019","unstructured":"Steels E, Venkatesh R, Steels E et al (2019) A double-blind randomized placebo controlled study assessing safety, tolerability and efficacy of palmitoylethanolamide for symptoms of knee osteoarthritis. Inflammopharmacology 27:475\u2013485. https:\/\/doi.org\/10.1007\/s10787-019-00582-9","journal-title":"Inflammopharmacology"},{"key":"1623_CR48","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/bph.v174.11\/issuetoc","volume":"174","author":"C Stefania Petrosino","year":"2017","unstructured":"Stefania Petrosino C, Petrosino S, Di Marzo V (2017) The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations LINKED ARTICLES. Br J Pharmacol 174:1349. https:\/\/doi.org\/10.1111\/bph.v174.11\/issuetoc","journal-title":"Br J Pharmacol"},{"key":"1623_CR49","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jpag.2014.12.011","volume":"28","author":"E Tartaglia","year":"2015","unstructured":"Tartaglia E, Armentano M, Giugliano B et al (2015) Effectiveness of the Association N-Palmitoylethanolamine and Transpolydatin in the Treatment of Primary Dysmenorrhea. J Pediatr Adolesc Gynecol 28:447\u2013450. https:\/\/doi.org\/10.1016\/j.jpag.2014.12.011","journal-title":"J Pediatr Adolesc Gynecol"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01623-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-024-01623-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01623-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T23:31:43Z","timestamp":1738711903000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-024-01623-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1623"],"URL":"https:\/\/doi.org\/10.1007\/s10787-024-01623-8","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}